Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Sonogene LLC
Profile last edited on: 9/4/13      CAGE: 484R5      UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2000
First Award
2009
Latest Award
2011
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

868 Baker Court
Glen Ellyn, IL 60137
   (630) 858-4000
   N/A
   www.sonegene.com
Location: Single
Congr. District: 06
County: DuPage

Public Profile

SonoGene LLC (SonoGene) is an early stage pharmaceutical discovery company developing novel platforms for therapeutic delivery of genes and pharmaceuticals using nonviral- mediated, ultrasound directed systems. SonoGene has developed a method for successfully delivering gene therapy for treatment of individuals with low HDL (Hypoaplphalipoproteinemia)

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
1
Conversion Rate
100.00%
Phase I Dollars
$94,281
Phase II Dollars
$718,896
Total Awarded
$813,177

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2011 2 NIH $813,177
Project Title: Development Of Novel Tissue Directed Ultra Sound Therapeutic Gene Delivery System

Key People / Management

  Eric Coles -- CEO

  Michael Davidson -- Vice President

  Steve Feinstein -- President

Company News

There are no news available.